hydralazine has been researched along with Disease, Pulmonary in 15 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure." | 7.96 | Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report. ( Al-Abdouh, A; Bekele, A; Garcia, P; Seid, H; Siyal, AM, 2020) |
| "Hydralazine-induced lupus was first described in 1953." | 5.48 | Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome. ( Aeddula, NR; Ansari, A; Juran, PJ; Pathireddy, S, 2018) |
| "Hydralazine, an arterial vasodilator, is a widely used medication for the management of hypertension and heart failure, especially for patients who cannot tolerate the use of ACEIs or ARBs." | 5.12 | Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review. ( Al-Sadawi, M; Battisha, A; Doughem, K; Konduru, L; Madoukh, B; Shaikh, S; Sheikh, O, 2021) |
| " We present a patient with hydralazine-induced antineutrophil cytoplasmic antibodies-positive vasculitis with a pulmonary-renal syndrome manifesting as pauci-immune glomerulonephritis and alveolar haemorrhage." | 4.31 | Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis. ( Acharya, I; Arend, LJ; Smith, LW; Weisman, DS, 2023) |
| "Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure." | 3.96 | Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report. ( Al-Abdouh, A; Bekele, A; Garcia, P; Seid, H; Siyal, AM, 2020) |
| "Hydralazine-induced lupus was first described in 1953." | 1.48 | Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome. ( Aeddula, NR; Ansari, A; Juran, PJ; Pathireddy, S, 2018) |
| "Hydralazine pretreatment reversed DE-induced TF, tPA, TNF-α, and MMP-2 expression but not eNOS, RAGE, and HMGB-1." | 1.39 | Diesel exhaust induced pulmonary and cardiovascular impairment: the role of hypertension intervention. ( Andrews, D; Bass, V; Gilmour, MI; King, C; Kodavanti, UP; Krantz, QT; Ledbetter, AD; Nyska, A; Richards, JE; Schladweiler, MC; Thomas, RF, 2013) |
| "Hydralazine is a commonly used drug for treatment of hypertension and is known to cause drug-induced lupus erythematosus." | 1.38 | Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation. ( Kaw, D; Malhotra, D; Marina, VP, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, I | 1 |
| Weisman, DS | 1 |
| Smith, LW | 1 |
| Arend, LJ | 1 |
| Al-Abdouh, A | 1 |
| Siyal, AM | 1 |
| Seid, H | 1 |
| Bekele, A | 1 |
| Garcia, P | 1 |
| Doughem, K | 1 |
| Battisha, A | 1 |
| Sheikh, O | 1 |
| Konduru, L | 1 |
| Madoukh, B | 1 |
| Al-Sadawi, M | 1 |
| Shaikh, S | 1 |
| Aeddula, NR | 1 |
| Pathireddy, S | 1 |
| Ansari, A | 1 |
| Juran, PJ | 1 |
| Kodavanti, UP | 1 |
| Thomas, RF | 1 |
| Ledbetter, AD | 1 |
| Schladweiler, MC | 1 |
| Bass, V | 1 |
| Krantz, QT | 1 |
| King, C | 1 |
| Nyska, A | 1 |
| Richards, JE | 1 |
| Andrews, D | 1 |
| Gilmour, MI | 1 |
| Kalra, A | 1 |
| Yokogawa, N | 1 |
| Raja, H | 1 |
| Palaniswamy, C | 1 |
| Desai, P | 1 |
| Zanotti-Cavazzoni, SL | 1 |
| Rajaram, SS | 1 |
| Marina, VP | 1 |
| Malhotra, D | 1 |
| Kaw, D | 1 |
| O'NEAL, RM | 2 |
| PERRY, HM | 2 |
| THOMAS, WA | 2 |
| Clark, BG | 1 |
| Vestal, RE | 1 |
| Hilliker, KS | 1 |
| Roth, RA | 1 |
| Bass, BH | 1 |
| Gavaghan, BJ | 1 |
| Lapointe, JM | 1 |
| Thomas, WP | 1 |
| Boman, G | 1 |
| Ohar, J | 1 |
| Polatty, C | 1 |
| Robichaud, A | 1 |
| Fowler, A | 1 |
| Vetrovec, G | 1 |
| Glauser, F | 1 |
| Ripe, E | 1 |
| Nilsson, BS | 1 |
1 review available for hydralazine and Disease, Pulmonary
| Article | Year |
|---|---|
Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis; Heart | 2021 |
14 other studies available for hydralazine and Disease, Pulmonary
| Article | Year |
|---|---|
Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; | 2023 |
Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis; Hemorrhage; | 2020 |
Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Biopsy; Blood Protein Electrophore | 2018 |
Diesel exhaust induced pulmonary and cardiovascular impairment: the role of hypertension intervention.
Topics: Albumins; Animals; Atherosclerosis; Cardiovascular Diseases; Hydralazine; Hypertension; Lung Disease | 2013 |
Hydralazine-induced pulmonary-renal syndrome: a case report.
Topics: Aged; Female; Glomerulonephritis; Glucocorticoids; Hemorrhage; Humans; Hydralazine; Immunosuppressiv | 2012 |
Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antihypertensive Agents; Glomerulonephri | 2012 |
Pulmonary disease following chronic chemical ganglionic blockade; a clinical and pathologic study.
Topics: Bis-Trimethylammonium Compounds; Hydralazine; Hypertension; Lung; Lung Diseases | 1957 |
Pulmonary disease following chronic chemical ganglionic blockade; a clinical and pathologic study.
Topics: Bis-Trimethylammonium Compounds; Hydralazine; Hypertension; Lung; Lung Diseases | 1957 |
Pulmonary disease following chronic chemical ganglionic blockade; a clinical and pathologic study.
Topics: Bis-Trimethylammonium Compounds; Hydralazine; Hypertension; Lung; Lung Diseases | 1957 |
Pulmonary disease following chronic chemical ganglionic blockade; a clinical and pathologic study.
Topics: Bis-Trimethylammonium Compounds; Hydralazine; Hypertension; Lung; Lung Diseases | 1957 |
Adverse drug reactions in the elderly: case studies.
Topics: Acetazolamide; Aged; Anemia, Hemolytic; Bromocriptine; Captopril; Chlorpropamide; Cimetidine; Clonid | 1984 |
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogen | 1984 |
Hydralazine lung.
Topics: Female; Humans; Hydralazine; Lung Diseases; Lupus Erythematosus, Systemic; Middle Aged | 1981 |
Acute onset of pulmonary necrotising arteritis in a dog with a left-to-right patent ductus arteriosus.
Topics: Acute Disease; Animals; Antihypertensive Agents; Dog Diseases; Dogs; Ductus Arteriosus, Patent; Echo | 1998 |
Negative consequences of blood pressure reduction. Respiratory aspects.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Ganglionic Blockers; Humans; Hydralazine; Lung | 1979 |
The role of vasodilators in patients with progressive systemic sclerosis. Interstitial lung disease and pulmonary hypertension.
Topics: Humans; Hydralazine; Hypertension, Pulmonary; Lung Diseases; Nifedipine; Pulmonary Fibrosis; Sarcoid | 1985 |
Pulmonary infiltrations during dihydralazine treatment in a slow isoniazid-inactivator.
Topics: Diagnosis, Differential; Half-Life; Humans; Hydralazine; Hypertension; Isoniazid; Lung; Lung Disease | 1972 |